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Ambient temperature affects energy intake and
expenditure to maintain homeostasis in a continu-
ously fluctuating environment. Here, mice with an
adipose-specific defect in fatty acid oxidation
(Cpt2A/) were subjected to varying temperatures
to determine the role of adipose bioenergetics in
environmental adaptation and body weight regula-
tion. Microarray analysis of mice acclimatized to
thermoneutrality revealed that Cpt2A/ interscapu-
lar brown adipose tissue (BAT) failed to induce the
expression of thermogenic genes such as Ucp1
and Pgc1a in response to adrenergic stimulation,
and increasing ambient temperature exacerbated
these defects. Furthermore, thermoneutral housing
induced mtDNA stress in Cpt2A/ BAT and ulti-
mately resulted in a loss of interscapular BAT.
Although the loss of adipose fatty acid oxidation re-
sulted in clear molecular, cellular, and physiologic
deficits in BAT, body weight gain and glucose toler-
ance were similar in control and Cpt2A/ mice in
response to a high-fat diet, even when mice were
housed at thermoneutrality.
INTRODUCTION
Obesity is driven by energy imbalance. Overconsumption of a
calorie-dense diet increases energy storage mainly as triglycer-
ide in white adipose tissue (WAT). Concomitantly, the inability to
use this energy potentiates adiposity and body weight gain.
Although great strides are being made in understanding the
regulation of food intake, less is known about the regulation
and contribution of energy expenditure to obesity. Determining
the tissue-specific contribution of macronutrient metabolism to
energy expenditure is critical for understanding the balance of
energy intake and expenditure.
WAT plays an important role in energy storage but contains
few mitochondria and contributes minimally to organismal bio-
energetics in an autonomous manner. Alternatively, brown adi-1308 Cell Reports 14, 1308–1316, February 16, 2016 ª2016 The Authpose tissue (BAT) is densely packed with mitochondria and
can rapidly and robustly affect whole animal energy expenditure
when deployed during a cold challenge (Harms and Seale, 2013).
The physiological role of BAT is to produce heat tomaintain body
temperature during a cold challenge. This is accomplished via
uncoupling cellular respiration from ATP generation via the mito-
chondrial transporter uncoupling protein-1 (Ucp1). Fatty acid
oxidation is critical for this process (Guerra et al., 1998; Schuler
et al., 2005; Tolwani et al., 2005) and provides the biophysical
activator of uncoupling in BAT (Fedorenko et al., 2012). Mice
with an adipose-specific loss of fatty acid oxidation are severely
cold intolerant, demonstrating an autonomous requirement for
adipose fatty acid oxidation in cold-induced thermogenesis (Ellis
et al., 2010; Lee et al., 2015).
Because of the large potential to alter energy expenditure, it is
tempting to suggest that defects in brown or beige adipocytes
can lead to an obesogenic phenotype. Therefore, it was some-
what surprising that uncoupling protein-1 knockout (Ucp1KO)
mice were resistant to rather than prone to diet-induced obesity
(Enerba¨ck et al., 1997; Liu et al., 2003). One caveat is that stan-
dard laboratory animal housing is below the thermal preference
for mice, generating a mild cold stress. Mice have a large sur-
face-to-volume ratio and need to expend large amounts of en-
ergy defending their body temperature against the environment.
Removing this cold stress by rearing mice at thermoneutrality
(30C) acutely reversed this phenotype and generated obesity-
prone Ucp1KO mice, revealing a strong environmental impact
on body weight and energy expenditure (Feldmann et al., 2009).
Recently, we generated mice with a loss of adipose fatty acid
oxidation by knocking out carnitine palmitoyltransferase 2
(Cpt2), an obligate step in mitochondrial long-chain fatty
acid b-oxidation (Lee et al., 2015). Similar to Ucp1KO mice,
Cpt2A/mice were severely cold intolerant, but mildly resistant
to high fat diet-induced adiposity. To understand the effect
of ambient temperature on BAT deficient in fatty acid oxidation,
we acclimatized Cpt2A/ mice to thermoneutrality (30C)
and demonstrate a severe loss of agonist-induced thermogenic
gene induction and loss of interscapular BAT after long-term
housing of Cpt2A/ mice at thermoneutrality. Surprisingly,
given the severity of cold intolerance and suppression of molec-
ular and cellular thermogenic programming in Cpt2A/ BAT,
thermoneutral housing did not affect diet-induced obesity inors
Cpt2A/ mice. These data show that bioenergetically and tran-
scriptionally incompetent BAT does not potentiate obesity, even
at thermoneutrality.
RESULTS
The Loss of Adipose Fatty Acid Oxidation Results in
Broad Transcriptional Dysregulation at
Thermoneutrality
Previously, we showed that the loss of an obligate step in mito-
chondrial long-chain fatty acid b-oxidation specifically in adipo-
cytes (Cpt2A/) resulted in severe cold intolerance (Lee et al.,
2015). Cold intolerance was expected given the critical role of
fatty acid oxidation for providing themitochondrial bioenergetics
and biophysical activator of uncoupling in BAT (Guerra et al.,
1998; Schuler et al., 2005; Tolwani et al., 2005). Unexpectedly,
Cpt2A/ BAT failed to upregulate thermogenic programming
in response to cold, b3-adrenergic agonists, or forskolin (Lee
et al., 2015). To better understand the role of fatty acid oxidation
on the transcriptional control of BAT, we acclimatized Cpt2A/
and littermate control mice to thermoneutrality (30C) for
2 weeks. Thermoneutrality relieves facultative thermogenesis
and reduces the requirement for basal tonic adrenergic signaling
in BAT. We then injected the mice with the selective b3-adren-
ergic agonist CL-316243 (10 mg/kg) or saline, collected inter-
scapular BAT 3 hr later, and preformed genome-wide gene
expression profiling on BATmRNA via DNAmicroarrays (Figures
1A and 1B). Microarray analysis revealed broad transcriptional
dysregulation upon the loss of fatty acid oxidation, particularly
in response to the b3-adrenergic agonist.
To validate themicroarray results in a larger cohort of mice, we
analyzed a subset of genes identified in the microarray analysis
by qRT-PCR. In agreement with our previous studies (Lee
et al., 2015), thermogenic genes Ucp1, Pgc1a, Elovl3, and
Dio2 failed to be induced upon b3-adrenergic stimulation in vivo
(Figure 1C). Alternatively, inguinal white adipose tissue (iWAT) of
Cpt2A/ mice exhibited significant suppression of Ucp1 but
was still responsive to b3-adrenergic stimulation (Figure S1).
Other models of BAT dysfunction have shown a switch in identity
from BAT to WAT (Cohen et al., 2014; Harms et al., 2014); how-
ever, Cpt2A/ BAT largely maintained its transcriptional identity
but again lost b3-adrenergic induction (Figure 1C). Loss of tri-
glyceride hydrolysis results in defects in b-oxidation and a loss
of Ppara signaling (Ahmadian et al., 2011; Haemmerle et al.,
2011; Mottillo et al., 2012; Schoiswohl et al., 2015). Cpt2A/
BAT did not exhibit a defect in Ppara, and the canonical Ppara
target Acot1 was increased at baseline; however, these genes
were again not induced by the b3-adrenergic agonist (Figure 1D).
Consistent with the metabolic defects induced upon the loss of
b-oxidation, Cpt2A/BAT exhibited defects in b3-adrenergic in-
duction of genes in several metabolic pathways, such as Gyk
(glycerolipid synthesis), Pdp2, and Pdk4 (pyruvate-tricarboxylic
acid cycle flux) (Figure 1E). Alternatively, iWAT remained sensi-
tive to b3-adrenergic stimulation and Pdp2 and Pdk4 showed
increased expression following CL-316243 injection (Figure S1).
The transcriptional deficits in BAT were mirrored by alterations in
the protein abundance for Ucp1, Pgc1a, and Acadm (Figure 1F).
These data show that the loss of fatty acid b-oxidation via ge-Cell Rnetic perturbation of Cpt2 results in a defective transcriptional
response to b3-adrenergic stimulation specifically in BAT.
The difference in agonist-induced thermogenic gene induction
between control and Cpt2A/ BAT at 30C was much larger
than that observed at lower ambient temperatures (Lee et al.,
2015). To understand whether this was due to a change in basal
expression or inducibility, control and Cpt2A/mice were accli-
matized for 2 weeks to 15C, 21C, or 30C and then injected
with saline or CL-316243 (10 mg/kg); interscapular BAT was
collected 3 hr later. We then analyzed the expression of Ucp1,
Pgc1a, and Dio2 (Figure 1G). Basal Ucp1 expression in wild-
type (WT) BAT increased with decreasing temperature but was
induced to the same degree. Ucp1 expression in Cpt2A/
BAT also increased with decreasing temperature but was not
induced at any temperature. Basal Pgc1a expression was mini-
mally altered by temperature acclimatization or genotype. How-
ever, Pgc1awas induced by adrenergic stimulation inWTBAT to
a greater degree upon increasing temperature, while Cpt2A/
BAT remained non-induced under all conditions (Figure 1G).
These data show that the primary transcriptional defect in
Cpt2A/ BAT is a failure in b3-adrenergic-induced rather than
basal thermogenic gene expression.
Role of Adipose Fatty Acid Oxidation on Thermogenic
Plasticity
Adipose fatty acid oxidation is required for acute cold-induced
thermogenesis (Ellis et al., 2010; Lee et al., 2015). Pre-acclimati-
zation to different ambient temperatures has dramatic effects on
the response to cold challenge. To understand the role of
adipose fatty acid oxidation on the physiology of thermogenic
plasticity, Cpt2A/ mice were acclimatized at thermoneutrality
(30C) for 2weeks and then placed in individual metabolic cages,
also maintained at 30C. After several days, to further acclima-
tize the mice to the metabolic cages, control and Cpt2A/
mice were injected with CL-316243 (10 mg/kg) and their energy
expenditure was monitored. As expected, Cpt2A/ mice failed
to increase their energy expenditure in response to b3-adren-
ergic stimulation and did not drop their respiratory exchange ra-
tio (RER), showing that they exhibited less fatty acid oxidation in
response to the adrenergic challenge (Figures 2A and 2B). We
then measured the energy expenditure of control and Cpt2A/
mice at 30C, and directly before the dark cycle, the temperature
was reduced (1C/4 min) to 22C (standard housing tempera-
ture) for 24 hr and then to 15C for an additional 24 hr. The energy
expenditure during this paradigm of temperature shifting was
unchanged between control and Cpt2A/ mice (Figure 2C).
However, consistent with the lack of adipose fatty acid oxidation
in Cpt2A/ mice, there was a strong shift toward carbohydrate
oxidation, as revealed by the RER (Figure 2D). In addition, all
mice showed an increase in food intake, and there was amodest
increase in food consumption of Cpt2A/ mice during this
experimental paradigm (Figure 2E). These data show that
although the Cpt2A/mice could not increase energy expendi-
ture via fatty acid oxidation in adipose tissue, a systemic
compensation enables homeostatic regulation of energy expen-
diture at different temperatures.
Next, we wanted to better understand howmice that could not
oxidize fatty acids in adipose tissue could maintain systemiceports 14, 1308–1316, February 16, 2016 ª2016 The Authors 1309
Figure 1. Transcriptional Response of Cpt2A/ BAT to Adrenergic Stimulation at Thermoneutrality
(A) Gene expression profiling via microarray of Cpt2, Cpt1b, and Acadm at thermoneutrality 3 hr after injection with vehicle or CL-316243-injected control and
Cpt2A/ BAT (n = 5).
(B) Heatmap of genes exhibiting statistically significant (p < 0.05) changes frommicroarray analyses for vehicle or CL-316243-injected control and Cpt2A/ BAT
(n = 3).
(C) mRNA expression in BAT of thermogenic and brown fat-enriched genes (n = 5).
(D) mRNA expression in BAT of Ppara and Ppara target genes (n = 5).
(E) mRNA expression in BAT of metabolic genes (n = 5).
(F) Western blots of BAT from control and Cpt2A/ mice at thermoneutrality.
(G) mRNA expression of Cpt2, Ucp1, Pgc1a, and Dio2 in BAT of control and Cpt2A/ mice after 2 weeks at 15C, 21C, and 30C injected with vehicle or CL-
316243 (n = 5).
Data are expressed as mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001.energy homeostasis. First, we measured blood acylcarnitines of
thermoneutral acclimatized control and Cpt2A/ mice injected
with CL-316243 (10 mg/kg) over 3 hr. Cpt2A/ mice were
slightly carnitine deficient but exhibited a rise in blood long-chain
acylcarnitines and a suppression of short-chain acylcarnitines
similar to controls (Figure 2F; Table S1). These data support a
systemic redistribution of fatty acids (Bartelt et al., 2011; Lee
et al., 2015). To understand possible compensatory adaptations1310 Cell Reports 14, 1308–1316, February 16, 2016 ª2016 The Authin Cpt2A/ adipose tissue, we mined our microarray data for
genes in creatine metabolism (Kazak et al., 2015). Consistent
with Ucp1KO mice, Cpt2A/ BAT exhibited an increase in
Ckmt2; however, Cpt2A/ BAT exhibited a loss of b3-adren-
ergic-induced Phospho1 expression, consistent with other ther-
mogenic genes (Figure 2G). In addition, Cpt2A/ iWAT exhibited
increased b3-adrenergic induction of Ckmt1, Ckmt2, Slc6a8,
and Phospho1 (Figure 2G). These data support the notion thators
Figure 2. Contribution of Adipose Fatty Acid Oxidation to Energy Expenditure at Different Temperatures
(A) O2 consumption of control and Cpt2
A/ mice injected with vehicle or CL-316243 (10 mg/kg) at thermoneutrality (n = 7).
(B) RER of control and Cpt2A/ mice injected with either vehicle or CL-316243 (10 mg/kg) at thermoneutrality (n = 7).
(C) O2 consumption of control and Cpt2
A/ mice at 30C, 22C, and 15C (n = 7).
(D) RER of control and Cpt2A/ mice at 30C, 22C, and 15C under dark and light cycles (n = 7).
(E) Food intake of control and Cpt2A/ mice at 30C, 22C, and 15C (n = 7).
(F) Hourly blood C18:1-carntine and L-carnitine concentrations of thermoneutral acclimatized control and Cpt2A/mice injectedwith CL-316243 (10mg/kg) over
3 hr (n = 5).
(G) mRNA expression in BAT and iWAT of genes in creatine metabolism (n = 5).
Data are expressed as mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001.when BAT thermogenesis is lost, temperature acclimatization re-
sults in systemic compensation to maintain energy homeostasis
during gradual changes in temperature.
Thermoneutrality Induces Mitochondrial DNA Stress
that Is Potentiated by the Loss of Fatty Acid Oxidation
To determine the role of adipose fatty acid oxidation during
long-term housing at thermoneutrality, we placed control and
Cpt2A/ male mice on a high-fat diet for 12 weeks housed in
a temperature- and light-controlled animal cabinet at 30C.
Upon necropsy, control mice had normal interscapular BAT.
However, we could not identify morphologically distinct BAT
in Cpt2A/ mice (Figure 3A). Upon histological examination of
interscapular adipose tissue, almost all of the classical BAT
morphology was absent (Figure 3B). The loss of adipose tissue
triglyceride lipase results in a suppression of Ppara and therefore
a switch of identity from BAT to a more WAT-like identity (Ahma-
dian et al., 2011; Schoiswohl et al., 2015).We did not observe de-
fects in Ppara or Ppara target genes at baseline (Figure 1D). In
addition, Cpt2A/ BAT did not exhibit alterations in BAT-spe-
cific identity (Figure 1C). However, increasing ambient tempera-
ture potentiated the loss of mtDNA in Cpt2A/ BAT (Figure 3C).
These data show that adipose fatty acid oxidation is required to
maintain BAT at thermoneutrality.
The loss of mtDNA via genetic deletion of the mitochondrial
transcriptional regulator Tfam was shown to induce interferon-
stimulated genes (ISGs) and initiate an innate antiviral responseCell R(West et al., 2015). Microarray analysis of thermoneutral acclima-
tized Cpt2A/BAT identified a similar gene expression profile. A
range of ISGs, such as Oasl2, Ifih1, Sp110, and p200 family pro-
teins Ifi203 and Ifi204, were induced in Cpt2A/ BAT. We went
on to verify a subset of these genes (Pyhin1, Ifit1, Ifit3, Usp18,
Isg15, Irf7, Viperin, and Ifi44) by qRT-PCR (Figure 3D). These
genes were induced regardless of adrenergic stimulation.
Adrenergic stimulation suppressed these genes in both control
and Cpt2A/ BAT (Figure 3D). To determine the role of ambient
temperature on the regulation of these ISGs, we profiled a subset
of genes (Pyhin1, Irf7, Ifi44, Ifit3, Usp18, and Viperin) in control
and Cpt2A/ BAT from mice acclimatized to 15C, 21C, and
30C. All ISGs increased in BAT as ambient temperature
increased, and the loss of fatty acid oxidation greatly potentiated
this response (Figure 3E). These data show that temperature im-
parts mtDNA stress in BAT, and this is greatly potentiated by a
loss in mitochondrial fatty acid b-oxidation.
The Absence of Adipose Fatty Acid Oxidation Does Not
Affect Obesity at Thermoneutrality
Thermoneutrality has been shown to dramatically and acutely in-
crease weight gain of Ucp1KO mice, particularly when they are
fed a high-fat diet (Feldmann et al., 2009). We predicted that ther-
moneutrality would impart an obesogenic phenotype onCpt2A/
mice, because Ucp1KO and Cpt2A/ mice have a similar
degree of cold intolerance. Cpt2A/ BAT is bioenergetically and
transcriptionally incompetent for thermogenesis, and long-termeports 14, 1308–1316, February 16, 2016 ª2016 The Authors 1311
Figure 3. Loss of Fatty Acid Oxidation Potentiates Mitochondrial DNA Stress
(A) Gross interscapular BAT morphology of control and Cpt2A/ mice after 12 weeks of high-fat (HF) diet at thermoneutrality.
(B) H&E-stained BAT from control and Cpt2A/ mice after 12 weeks of HF diet at thermoneutrality. Arrows indicate BAT morphology. Scale bar, 100 mM.
(C) mtDNA fold suppression of control and Cpt2A/ BAT at 15C and 30C (n = 5).
(D) mRNA expression in BAT of ISGs in BAT of control and Cpt2A/ mice injected with vehicle or CL-316243 at thermoneutrality (n = 5).
(E) mRNA expression in BAT of ISGs in control and Cpt2A/ mice after 2 weeks at 15C, 21C, and 30C (n = 5).
Data are expressed as mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001.housing at 30C facilitates an almost complete loss of BAT.
Therefore, we measured the body weight weekly of control and
Cpt2A/ mice for 12 weeks fed a high-fat diet and housed at
30C. Surprisingly, thermoneutral housing did not affect weight
gain in Cpt2A/mice (Figure 4A). Adiposity was also not affected1312 Cell Reports 14, 1308–1316, February 16, 2016 ª2016 The Authand even trended lower (Figures 4B and 4C), similar to high-fat
feeding at room temperature (Lee et al., 2015). In addition, there
was no change in glucose tolerance (Figure 4D), little change in
serum chemistry (Figure 4E), and no significant beiging of iWAT
(Figure S2) upon deletion of mitochondrial fatty acid b-oxidationors
Figure 4. The Loss of Adipose Fatty Acid Oxidation Does Not Potentiate Diet-Induced Obesity at Thermoneutrality
(A) Body weights of control and Cpt2A/male mice fed a high-fat diet from 6 weeks of age at thermoneutrality (n = 11–13). Arrow indicates the beginning of the
high-fat diet.
(B) Fat and lean mass of control and Cpt2A/ mice at 18 weeks of age after 12 weeks on a high-fat diet at thermoneutrality (n = 11–13).
(C) Wet weights of iWAT, gWAT (unilateral depots), and liver (left lobe) of control and Cpt2A/ mice (n = 11–13).
(D) Intraperitoneal glucose tolerance test (ipGTT), including the area under the curve (AUC), for control and Cpt2A/ mice at 10 weeks on a high-fat diet at
thermoneutrality (n = 11–13).
(E) Serum metabolite levels of control and Cpt2A/ mice fed a high-fat diet at thermoneutrality (n = 9).
Data are expressed as mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001.in adipose tissue. These data suggest that defects in adipose tis-
sue bioenergetics alone cannot account for the etiology of obesity
or diabetes.
DISCUSSION
BAT gene expression and thermogenic potential are highly
correlated with the regulation of body weight and susceptibility
to high fat diet-induced obesity across many mouse models
(Harms and Seale, 2013). The loss of Ucp1 (Enerba¨ck et al.,
1997; Liu et al., 2003) or adipose fatty acid oxidation (Ellis
et al., 2010; Lee et al., 2015) generates severe cold intolerance
but does not result in susceptibility to diet-induced obesity under
standard laboratory housing conditions. Therefore, it seems un-
likely that mice with an obesogenic phenotype at room temper-
ature can be explained via a defect in BAT bioenergetics alone.
Thermoneutrality revealed an obesogenic phenotype of Ucp1KO
mice (Feldmann et al., 2009); however, we were not able to reca-
pitulate this effect in Cpt2A/ mice, although they had molecu-
lar, cellular, and biochemical defects that prevented canonical
BAT or beige cell function.
It seems logical that losing the ability to burn lipid stores within
adipocytes would result in increased triglyceride accumulationCell Rand potentiate obesity. Therefore, it is somewhat counterintui-
tive that Cpt2A/ mice did not show increased high fat diet-
induced weight gain at any temperature. Long-term housing of
Cpt2A/ mice at thermoneutrality resulted in almost complete
loss of classical BAT without increasing adiposity or glucose
intolerance. It is not clear how aging might affect body weight
gain in Cpt2A/mice (Kontani et al., 2005). These data suggest
the current model for BAT function or dysfunction in obesity is
more complex than originally envisioned. Our results suggest
that although BAT dysfunction is tightly correlated with obesity,
BAT function is likely correlating with the main driver of whole
body energy expenditure that has yet to be defined mechanisti-
cally. In support of this notion, fibroblast growth factor-21 has a
strong effect on BAT but can increase energy expenditure and
induce weight loss equally well in WT or Ucp1KO mice even at
thermoneutrality (Fisher et al., 2012; Samms et al., 2015; Ve´niant
et al., 2015). In addition, the transplantation of large quantities of
BAT inmice produced onlymild benefits to bodyweight gain that
were dependent on interleukin-6, suggesting an endocrine rather
than a bioenergetic role of BAT (Stanford et al., 2013).
Triglyceride lipolysis and fatty acid oxidation are largely inter-
dependent. Consequently, the loss of the rate-setting step in tri-
glyceride hydrolysis, adipocyte triglyceride lipase (Atgl), resultseports 14, 1308–1316, February 16, 2016 ª2016 The Authors 1313
in cold intolerance (Ahmadian et al., 2011). The knockout (KO) of
Atgl with ap2/Fabp4-Cre generates mice that are obese with
increased adiposity (Ahmadian et al., 2011). However, the KO
of Atgl with the more specific adiponectin-Cre generates mice
that are not more prone to obesity even after high-fat feeding
(Schoiswohl et al., 2015). This suggests that the increase in
body weight and adiposity induced by a loss in adipocyte triglyc-
eride hydrolysis requires simultaneous deletion in cells other
than adipocytes (such as macrophages). The loss of adipose
fatty acid catabolism at either b-oxidation or triglyceride hydroly-
sis has little effect on the progression of obesity. These models
may bemitigated by suppressing lipid uptake or de novo synthe-
sis or by shifting bioenergetic demands to other tissues. Alterna-
tively, adipose bioenergetics per say may be dispensable in
body weight regulation in relation to whole animal physiology.
The loss of Atgl results in the loss of Ppara-directed transcrip-
tion and the loss of BAT identity, presumably from the loss of
an endogenous Ppara ligand produced upon hydrolysis (Ahma-
dian et al., 2011; Haemmerle et al., 2011; Mottillo et al., 2012;
Schoiswohl et al., 2015). Cpt2-deficient BAT maintains a BAT-
like transcriptional program and is not deficient in Ppara-medi-
ated transcription. There is more Ppara target gene expression
in Cpt2A/ BAT, likely due in part to the increase in basal adren-
ergic activity and protein kinase A signaling (Lee et al., 2015). The
main defect in Cpt2A/ BAT is due to the loss in adrenergic-
induced gene expression with limited changes to basal gene
expression. Although lipolysis and b-oxidation are intimately
linked within a continuous pathway, these data show that fatty
acid catabolism affects transcription at multiple independent
steps, suggesting a complex integration of metabolites and tran-
scriptional programming.
One of the most surprising results from the current study was
the increase in ISGs in Cpt2A/ BAT. The loss of Cpt2 and the
loss of Tfam have a high degree of concordance between the
ISGs induced (West et al., 2015). However, the suppression in
mtDNA was specific to BAT in Cpt2A/ mice, because mtDNA
was unchanged in gonadal WAT (gWAT), iWAT, or mouse em-
bryonic fibroblasts deleted in Cpt2 (Lee et al., 2015). This sug-
gests that cells that undergo high fatty acid oxidation may be
more susceptible to mtDNA stress, while loss of Tfam affects
mtDNA stress more globally. It will be interesting to see whether
other tissue-specific KOs of Cpt2 enhance innate immune prim-
ing, particularly macrophages. The mtDNA stress and ISG
expression was increased in WT mice with increasing tempera-
ture, and this was greatly potentiated by the loss of fatty acid
oxidation. Thermoneutrality exhibits an array of beneficial phys-
iologic adaptations not overtly associated with energy homeo-
stasis, including significant improvements in tumor therapy
(Eng et al., 2015; Kokolus et al., 2013). In addition, thermoneu-
trality increases macrophage recruitment to adipose tissue
(Tian et al., 2016). It is tempting to speculate that thermoneutral-
ity initiates a priming of the innate immune system via mitochon-
drial metabolism that improves tumor clearance and antiviral
activity.
Small mammals with large surface-to-volume ratios can
expend a large amount of energy defending their body tempera-
tures against the environment and have a large capacity for
thermogenesis. Altering the ambient temperature results in an1314 Cell Reports 14, 1308–1316, February 16, 2016 ª2016 The Authamazing array of molecular, cellular, and physiological adapta-
tions to maintain body temperature and energy homeostasis.
Adipocyte fatty acid oxidation plays a major role in both medi-
ating and regulating these processes. Micewith an adipose-spe-
cific loss of fatty acid oxidation are unable to maintain their body
temperature during an acute cold challenge (Lee et al., 2015).
However, in response to moderate environmental challenges,
they are able to maintain energy homeostasis via alternative
mechanisms. The control of energy expenditure represents a
critical evolutionarily conserved survival mechanism that is likely
regulated by multiple overlapping and compensatory systems,
which may present both opportunities and challenges for devel-
oping treatments aimed at reversing human obesity.
EXPERIMENTAL PROCEDURES
Animals
Cpt2lox/lox and Cpt2A/ mice and diets were previously described (Lee et al.,
2015). Control mice are defined as sex-matched Cpt2lox/lox littermates. For the
diet study, Cpt2lox/lox andCpt2A/micewere fed a 60%high-fat diet (D12492,
Research Diets) starting at 6 weeks of age and continuing for 12 weeks. For
temperature acclimation studies, Cpt2lox/lox and Cpt2A/ mice were housed
at the indicated temperatures for 2 weeks in an animal incubator (Key Scienti-
fic) on a 12 hr light/12 hr dark cycle. Serum was collected from all mice to
measure free glycerol and triacylglycerol (Sigma), b-hydroxybutyrate (Stan-
Bio), total cholesterol (Wako), and non-esterified fatty acid (Wako). Blood acyl-
carnitines were quantified from dried blood spots (DBSs) with modifications
(Chace et al., 1997; Sandlers et al., 2012). Punched one-eighth-inch DBS sam-
ples were submerged in 100 ml of methanol solution containing internal acyl-
carnitine standards (NSK B, Cambridge Isotopes). Samples were incubated
at 4C for 20 min and dried under the nitrogen; then 60 ml 3N HCl in n-butanol
was added. The samples were incubated for 15 min at 65C and then dried
under LN2, and butylated acylcarnitines were reconstituted in 100 ml of mobile
phase acetonitrile/water/formic acid (H2O:CH3CN:HCOOH, 80:19.9:0.1 v/v%).
Samples were vortexed, transferred to a centrifuge filter, spun, and transferred
to injection vial. Acylcarnitines were analyzed on an API 3200 (AB Sciex) oper-
ated in positive ion mode employing a precursor ion scan for m/z 85, which is
generated as a characteristic product ion of butyl ester of acylcarnitine spe-
cies. Quantitation of acylcarnitines was achieved by Chemoview (AB Sciex)
application. Body composition was measured using quantitative nuclear mag-
netic resonance technology (Echo-MRI-100) to determine fat and lean mass.
Energy expenditure and RER were measured using Oxymax indirect calorim-
etry cages (Columbus Instruments). All procedures were performed in accor-
dance with the NIH’s Guide for the Care and Use of Laboratory Animals and
under the approval of the Johns Hopkins Medical School Animal Care and
Use Committee.
Analysis of Gene Expression and mtDNA
Trizol followed by the RNeasy Mini Kit (QIAGEN) was used to obtain total
RNA. Microarray analysis was done using affymetrix mouse exon arrays
(GSE72210). For qRT-PCR, 1–2 mg of RNA was reverse transcribed using
the High Capacity cDNA Reverse Transcription Kit (Applied Biosciences).
cDNA was diluted to 2 ng/ml and was amplified by specific primers in a 20 ml
reaction using SsoAdvanced SYBR Green Supermix (Bio-Rad). Analysis of
gene expression was carried out in a CFX Connect Real-Time System (Bio-
Rad). For each gene, mRNA expression was calculated as 2^deltaCT relative
to cyclophilin A expression. For mtDNA analysis, total DNA was prepared us-
ing the QIAmp DNA Mini Kit (QIAGEN). Primer and gene information are pro-
vided in Table S2.
Western Blots
For western blots, protein was obtained by homogenizing tissues in 1x radio-
immunoprecipitation assay buffer (50 mM Tris-Cl pH 7.4, 150 mM NaCl, 1 mM
EDTA, 1% Triton X-100, 0.25% deoxycholate). The concentration of theors
protein was obtained using the BCA Protein Assay Reagent (Pierce). Then
30 mg of protein was used in an SDS-PAGE and transferred to either a nitrocel-
lulose (Protran BA 83, Whatman) or a polyvinylidene fluoride membrane and
blocked with 3% BSA-Tris-buffered saline with Tween 20. The blots
were probed with the following antibodies: CPT2 (Thermo Scientific), ACADM
(GeneTex), UCP1 (Abcam), Pgc1a (Abcam), ATP5A (Abcam), and heat shock
cognate 70 (Hsc70; Santa Cruz Biotechnology). Cy3 fluorescent antibody
was used for Hsc70, and the corresponding secondary antibodies conjugated
to horseradish peroxidase were used for other primary antibodies.
Statistic Analyses
Multiple comparisons were calculated using ANOVA. Acylcarnitines were
analyzed using repeated-measures ANOVAwith a Bonferroni post hoc correc-
tion. Pairwise comparisons were calculated using a two-tailed Student’s t test.
Significance was determined as *p < 0.05; **p < 0.01;***p < 0.001.
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